Schrödinger Receives Milestone Payment from Sanofi Collaboration


NEW YORK–(BUSINESS WIRE)–Schrödinger today announced receipt of a preclinical milestone payment from Sanofi in a drug discovery program advancing as part of a multi-year, multi-target collaboration between the two companies. Under the terms of the collaboration, Schrödinger provides advanced molecular simulation and computational design expertise to Sanofi across multiple stages of drug discovery, from target analysis and lead optimization to identification of a development candidate. Earlier…


- Advertisement -